ABBV has outperformed the market over the past 5 years

DividendWave
01-12

$AbbVie(ABBV)$ The ABBV investment thesis in one sentence:

Botox has a commanding 68% share of the lucrative aesthetics market

You don't have to try to be a hero when it comes to investing, sometimes it's just a simple idea

ABBV has outperformed the market over the past 5 years

ImageImage

ABBV will pay dividend on JEN12, 3.8% yield currently, and 4.3% for 4 year avg yield.

ImageImage

https://twitter.com/DividendWave/status/1745097530239586706

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • S071
    01-12
    S071
    note patents expiry dates...
Leave a comment
1
24